Clinical Trial Update: MK0524 Asthma POC Study (0524-008)(COMPLETED) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 proof-of-concept study of MK0524 in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0524

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED